HK

Helen Kurincic

Estia Health Limited | Non-Executive Director
Ms Kurincic is Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, HBF Health Limited and the Victorian Clinical Genetics Service. Formerly, Ms Kurincic was the Chief Operating Officer and Director of Genesis Care from its inception, creating and developing the first and radiation oncology and cardiology business across Australia. She has also formerly held Board roles across the publicly listed, private, not-for-profit and government sectors as well as being the former CEO of Benetas and Heart Care Victoria. Ms Kurincic is a Fellow of the Australian Institute of Company Directors and Governance Institute of Australia. She has also completed the Cambridge Institute for Sustainability Leadership NED Programme.

Companies and Roles

Company
Title
Tenure
Since
EHE
Estia Health Limited
  • Non-Executive Director
6yrs, 9mthJul 2017
MMS
McMillan Shakespeare Limited
  • Non-Executive Director
  • Non-Executive Chairman
5yrs, 7mthSep 2018
RHC
Ramsay Health Care Limited
  • Non-Executive Director
1mthMar 2024

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RHC
Ramsay Health Care Limited
01/03/2401,360N/AN/A
29/11/23N/A555,579N/AN/A
EHE
Estia Health Limited
13/10/2325,00025,000N/AN/A
MMS
McMillan Shakespeare Limited
30/06/23N/A25,000N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
MMS
McMillan Shakespeare Limited
28/11/22
Buy
4,566$13.575$61,985On-market trade
MMS
McMillan Shakespeare Limited
04/11/22
Buy
434$13.270$5,759On-market trade
22/02/22
Issued
63,495$3.440$218,422Rights issue
EHE
Estia Health Limited
04/03/20
Buy
25,000$1.830$45,750On-market trade
MMS
McMillan Shakespeare Limited
21/02/20
Buy
9,000$11.972$107,744On-market trade